1. Home
  2. FDUS vs MDXG Comparison

FDUS vs MDXG Comparison

Compare FDUS & MDXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fidus Investment Corporation

FDUS

Fidus Investment Corporation

N/A

Current Price

$19.44

Market Cap

775.5M

Sector

Finance

ML Signal

N/A

Logo MiMedx Group Inc

MDXG

MiMedx Group Inc

N/A

Current Price

$3.19

Market Cap

672.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
FDUS
MDXG
Founded
2011
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Finance/Investors Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
775.5M
672.8M
IPO Year
2011
2007

Fundamental Metrics

Financial Performance
Metric
FDUS
MDXG
Price
$19.44
$3.19
Analyst Decision
Buy
Strong Buy
Analyst Count
5
5
Target Price
★ $21.60
$7.00
AVG Volume (30 Days)
270.1K
★ 1.8M
Earning Date
11-05-2026
10-28-2026
Dividend Yield
★ 11.28%
N/A
EPS Growth
N/A
★ 14.29
EPS
★ 1.68
N/A
Revenue
N/A
★ $418,630,000.00
Revenue This Year
$17.63
N/A
Revenue Next Year
$0.42
$12.42
P/E Ratio
$11.51
★ N/A
Revenue Growth
N/A
★ 19.99
52 Week Low
$16.87
$3.03
52 Week High
$20.78
$7.51

Technical Indicators

Market Signals
Indicator
FDUS
MDXG
Relative Strength Index (RSI) 52.90 25.43
Support Level $19.20 $3.09
Resistance Level $19.81 $3.84
Average True Range (ATR) 0.33 0.22
MACD 0.03 -0.02
Stochastic Oscillator 53.13 13.47

Price Performance

Historical Comparison
FDUS
MDXG

About FDUS Fidus Investment Corporation

Fidus Investment Corp is an externally managed, closed-end, non-diversified management investment company that has elected to be treated as a business development company. The company provides customized debt and equity financing solutions to lower middle-market companies. Its investment objective is to provide attractive risk-adjusted returns by generating both current income from debt investments and capital appreciation from equity related investments. The company's portfolio of investment is comprised of securities of companies from different industries such as, Information Technology Services, Business Services, Healthcare Products among others.

About MDXG MiMedx Group Inc

MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, the company sells allografts for ophthalmic surgery and dental applications through licenses to third parties.

Share on Social Networks: